BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 102631)

  • 1. In vitro activity of HR 756, a new cephalosporin compound.
    Shah PM; Troche G; Stille W
    J Antibiot (Tokyo); 1978 Nov; 31(11):1170-4. PubMed ID: 102631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Influence of human albumin on bactericidal or antibacterial activities of cephems and monobactams].
    Saionji K
    Jpn J Antibiot; 1988 Oct; 41(10):1390-406. PubMed ID: 3144613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial activity of a new parenteral cephalosporin--HR 756: comparison with cefamandole and ceforanide.
    Counts GW; Turck M
    Antimicrob Agents Chemother; 1979 Jul; 16(1):64-8. PubMed ID: 112919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro activity of cefoxitin, a new cephalosporin (author's transl)].
    Shah PM; Zwischenbrugger H; Stille W
    MMW Munch Med Wochenschr; 1976 Nov; 118(45):1469-72. PubMed ID: 825763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vitro activity of Ro 09-1428, a novel cephalosporin with a catechol moiety.
    Qadri SM; Ayub A; Ueno Y; Saldin H
    Clin Ther; 1992; 14(4):562-9. PubMed ID: 1525790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of a new semisynthetic cephalosporin: cefoperazone.
    Auckenthaler R; Waldvogel FA
    Clin Ther; 1980; 3(Spec Issue):89-97. PubMed ID: 6446401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro activity of cefepime against nosocomial isolates.
    Sofianou D; Tsoulfa S; Kontodimou L; Polydorou F; Malaka E
    J Chemother; 1997 Oct; 9(5):341-6. PubMed ID: 9373789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
    Jones RN; Barry AL; Thornsberry C; Gerlach EH; Fuchs PC; Gavan TL; Sommers HM
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HR 756, a new cephalosporin active against gram-positive and gram-negative aerobic and anaerobic bacteria.
    Neu HC; Aswapokee N; Aswapokee P; Fu KP
    Antimicrob Agents Chemother; 1979 Feb; 15(2):273-81. PubMed ID: 426518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In-vitro activity of cefonicid on hospital bacteria. Regression line and proposal for critical values].
    Chanal M; Cluzel M; Sirot D; Joly B; Sirot J; Cluzel R
    Pathol Biol (Paris); 1986 May; 34(5):385-9. PubMed ID: 3095773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and microbial susceptibility studies of ceftriaxone.
    Baumgartner JD; Glauser MP
    Eur J Clin Microbiol; 1983 Oct; 2(5):501-4. PubMed ID: 6315426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro antimicrobial activity of cefotaxime, a new cephalosporin.
    Masuyoshi S; Arai S; Miyamoto M; Mitsuhashi S
    Antimicrob Agents Chemother; 1980 Jul; 18(1):1-8. PubMed ID: 6251749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GR-20263: a new aminothiazolyl cephalosporin with high activity against Pseudomonas and Enterobacteriaceae.
    Verbist L; Verhaegen J
    Antimicrob Agents Chemother; 1980 May; 17(5):807-12. PubMed ID: 6994640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro evaluation of cefoxitin and cefamandole.
    Adams HG; Stilwell GA; Turck M
    Antimicrob Agents Chemother; 1976 Jun; 9(6):1019-24. PubMed ID: 820241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial activity in vitro of cefaclor, a new oral cephalosporin.
    Meyers BR; Hirschman SZ
    J Clin Pharmacol; 1978; 18(2-3):85-90. PubMed ID: 624778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of the in vitro activity of cefoperazone: a comparison with other beta-lactam antibiotics.
    Wise R; Gillett AP; Andrews JM
    Clin Ther; 1980; 3(Spec Issue):149-55. PubMed ID: 6446391
    [No Abstract]   [Full Text] [Related]  

  • 17. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)].
    Ikemoto H; Ito C; Yoshida T; Watanabe K; Mori T; Ohno I; Okada S; Igari J; Arakawa M; Igarashi K; Oguri T; Okada M; Ozaki K; Terai T; Aoki N; Inoue H; Nakadate T; Kitamura N; Sekine O; Suzuki Y; Ando M; Suga M; Sato K; Nakata K; Kusano N
    Jpn J Antibiot; 1999 May; 52(5):353-97. PubMed ID: 10480048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefazaflur, a new parenteral cephalosporin: in vitro studies.
    Counts GW; Gregory D; Zeleznik D; Turch M
    Antimicrob Agents Chemother; 1977 Apr; 11(4):708-11. PubMed ID: 324399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of in vitro antimicrobial activity of cefazolin alone and in combination with cefmetazole or flomoxef using agar dilution method and disk diffusion method].
    Matsuo K; Uete T
    Jpn J Antibiot; 1992 Oct; 45(10):1253-66. PubMed ID: 1479676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Piperacillin (T-1220), a new semisynthetic penicillin: in vitro antimicrobial activity comparison with carbenicillin, ticarcillin, ampicillin, cephalothin, cefamandole and cefoxitin.
    Jones RN; Thornsberry C; Barry AL; Fuchs PC; Gavan TL; Gerlach EH
    J Antibiot (Tokyo); 1977 Dec; 30(12):1107-14. PubMed ID: 599084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.